Research Topics
| Maija ItalaSummaryAffiliation: University of Turku Country: Finland Publications
| Collaborators
|
Detail Information
Publications
Standard-dose anti-CD20 antibody rituximab has efficacy in chronic lymphocytic leukaemia: results from a Nordic multicentre studyM Itala
Haematological Departments of Turku University Hospital, Finland Rigshospitalet, Copenhagen, Denmark
Eur J Haematol 69:129-34. 2002..Secondary objectives were defined as the tolerability and feasibility of rituximab in patients with CLL...- Excellent response of refractory life-threatening thrombotic thrombocytopenic purpura to cyclosporine treatmentM Itala
Department of Medicine, Turku University Central Hospital, Turku, Finland
Clin Lab Haematol 26:65-7. 2004..Cyclosporine was tapered off after 6 months treatment, and the patient has stayed in remission ever since. We conclude that cyclosporine is a worthwhile treatment option in patients with refractory TTP... - Reduced-intensity conditioning and blood stem cell transplantation from an HLA-identical sibling for severe aplastic anaemia: two patients with successful engraftment but a fatal post-transplant lymphoproliferative disorder in the otherMaija Itala
Department of Medicine, Turku University Central Hospital, PL 52, Turku, 20521 Finland
Hematol J 5:440-3. 2004.... 
Stem cell transplantation in poor-risk chronic lymphocytic leukemia: assessment of post-transplant minimal residual disease using four- and six-color flow cytometry and allele-specific RQ-PCRMaija Itala
Department of Medicine, Turku University Central Hospital, Turku, Finland
Eur J Haematol 81:100-6. 2008..001 and <0.003), two of them having non-myeloablative conditioning. None of the patients who became PCR-negative after allogeneic transplantation have relapsed...- Autologous stem cell transplantation in patients with mantle cell lymphomaRiikka Oinonen
Department of Medicine, Helsinki University Central Hospital, Finland
Leuk Lymphoma 43:1229-37. 2002..However, no plateau was seen in the EFS curve after ASCT. Whether cure Can be achieved in a proportion of patients with ASCT is currently unknown and should be studied in larger patient series with a longer follow-up... - A randomised phase III study comparing high-dose chemotherapy to conventionally dosed chemotherapy for stage III ovarian cancer: the Finnish Ovarian Cancer (FINOVA) studySeija Grenman
Department of Obstetrics and Gynaecology, Turku University Hospital, PL 52, 20521 Turku, Finland
Eur J Cancer 42:2196-9. 2006..We conclude that the HDCT regimen used was feasible, but did not result in significantly improved survival in this prematurely closed trial. A clinically important survival benefit cannot be excluded due to the small sample size... - Percutaneous coronary intervention with stenting in a patient with haemophilia A and an acute myocardial infarction following a single dose of desmopressinRaine Virtanen
Department of Medicine, Turku University Central Hospital, FIN-20520 Turku, Finland
Thromb Haemost 92:1154-6. 2004 - [Directions for allogenic stem cell transplants and how they reflect on the operation and results of the transfer center in Turku]Kari Remes
, Turku
Duodecim 121:2085-97. 2005 - Long-term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML-92 study by the Finnish Leukaemia GroupPirjo Koistinen
Department of Medicine, Oulu University Hospital, Oulu, Finland
Eur J Haematol 78:477-86. 2007..To investigate the long-term outcome of idarubicin- and cytarabine-based intensive chemotherapy in adult acute myeloid leukaemia (AML)...